Overexpression of SOX2 Is Associated with Better Overall Survival in Squamous Cell Lung Cancer Patients Treated with Adjuvant Radiotherapy
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose The purpose of this study is to investigate the prognostic significance of SOX2 gene amplification and expression in patients with American Joint Committee on Cancer stage III lung squamous cell carcinoma (SCC) who underwent surgery followed by adjuvant radiotherapy. Materials and Methods Pathological specimens were obtained from 33 patients with stage III lung SCC treated with surgery followed by adjuvant radiotherapy between 1996 and 2008. SOX2 gene amplification and protein expression were analyzed using fluorescent in situ hybridization and immunohistochemistry, respectively. Patients were divided into two groups according to their SOX2 gene amplification and protein expression status. Kaplan-Meier estimates and a Cox proportional hazards model were used to identify the prognostic factors affecting patient survival. Results The median follow-up period for surviving patients was 58 months (range, 5 to 102 months). SOX2 gene amplification was observed in 22 patients and protein overexpression in 26 patients. SOX2 overexpression showed significant association with SOX2 gene amplification (p=0.002). In multivariate analysis, SOX2 overexpression was a significant prognostic factor for overall survival (OS) (hazard ratios [HR], 0.1; 95% confidence interval [CI], 0.002 to 0.5; p=0.005) and disease-free survival (DFS) (HR, 0.15; 95% CI, 0.04 to 0.65; p=0.01). Age (HR, 0.33; 95% CI, 0.11 to 0.98; p=0.046) and total radiation dose (HR, 0.13; 95% CI, 0.02 to 0.7; p=0.02) were the independent prognostic factors for OS and DFS. Patients with SOX2 amplification did not show a longer OS (p=0.95) and DFS (p=0.48). Conclusion Our data suggested that SOX2 overexpression could be used as a positive prognostic factor in patients with stage III lung SCC receiving adjuvant radiotherapy.
Abstract
Purpose The purpose of this study is to investigate the prognostic significance of SOX2 gene amplification and expression in patients with American Joint Committee on Cancer stage III lung squamous cell carcinoma (SCC) who underwent surgery followed by adjuvant radiotherapy. Materials and Methods Pathological specimens were obtained from 33 patients with stage III lung SCC treated with surgery followed by adjuvant radiotherapy between 1996 and 2008. SOX2 gene amplification and protein expression were analyzed using fluorescent in situ hybridization and immunohistochemistry, respectively. Patients were divided into two groups according to their SOX2 gene amplification and protein expression status. Kaplan-Meier estimates and a Cox proportional hazards model were used to identify the prognostic factors affecting patient survival. Results The median follow-up period for surviving patients was 58 months (range, 5 to 102 months). SOX2 gene amplification was observed in 22 patients and protein overexpression in 26 patients. SOX2 overexpression showed significant association with SOX2 gene amplification (p=0.002). In multivariate analysis, SOX2 overexpression was a significant prognostic factor for overall survival (OS) (hazard ratios [HR], 0.1; 95% confidence interval [CI], 0.002 to 0.5; p=0.005) and disease-free survival (DFS) (HR, 0.15; 95% CI, 0.04 to 0.65; p=0.01). Age (HR, 0.33; 95% CI, 0.11 to 0.98; p=0.046) and total radiation dose (HR, 0.13; 95% CI, 0.02 to 0.7; p=0.02) were the independent prognostic factors for OS and DFS. Patients with SOX2 amplification did not show a longer OS (p=0.95) and DFS (p=0.48). Conclusion Our data suggested that SOX2 overexpression could be used as a positive prognostic factor in patients with stage III lung SCC receiving adjuvant radiotherapy.
참고문헌 (25)
- Kyu-Won Jung, "Prediction of Cancer Incidence and Mortality in Korea, 2012", Cancer Research and Treatment, 44(1), pp.15~31 (2012), 대한암학회
- Jemal A, "Global cancer statistics", CA Cancer J Clin, 61, pp.69~90 (2011)
- Bass AJ, "SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas", Nat Genet, 41, pp.1238~1242 (2009)
- Sutherland KD, "Cell of origin of lung cancer", Mol Oncol, 4, pp.397~403 (2010)
- Long KB, "SOX2 is highly expressed in squamous cell carcinomas of the gastrointestinal tract", Hum Pathol, 40, pp.1768~1773 (2009)
- Yuan P, "Sex determining region Y-Box 2(SOX2)is a potential celllineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung", PLoS One, 5, pp.9112~ (2010)
- Velcheti V, "High SOX2 levels predict better outcome in nonsmall cell lung carcinomas", PLoS One, 8, pp.61427~ (2013)
- Wilbertz T, "SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer", Mod Pathol, 24, pp.944~953 (2011)
- Greene FL, "AJCC cancer staging manual" (2002), Springer
- Gontan C, "Sox2 is important for two crucial processes in lung development : branching morphogenesis and epithelial cell differentiation", Dev Biol, 317, pp.296~309 (2008)
- Hussenet T, "SOX2 in squamous cell carcinoma : amplifying a pleiotropic oncogene along carcinogenesis", Cell Cycle, 9, pp.1480~1486 (2010)
- Liu K, "The multiple roles for Sox2 in stem cell maintenance and tumorigenesis", Cell Signal, 25, pp.1264~1271 (2013)
- Singh S, "EGFR", Src, Mol Cancer, pp.2012, 11[DOI]
- Chen S, "SOX2 gene regulates the transcriptional network of oncogenes and affects tumorigenesis of human lung cancer cells", PLoS One, 7, pp.36326~ (2012)
- Chen S, "SOX2 regulates apoptosis through MAP4K4-survivin signaling pathway in human lung cancer cells", Carcinogenesis, 35, pp.613~623 (2014)
- Wu F, "Identification of two novel phenotypically distinct breast cancer cell subsets based on Sox2 transcription activity", Cell Signal, 24, pp.1989~1998 (2012)
- Lin F, "Sox2 targets cyclinE, p27 and survivin to regulate androgen-independent human prostate cancer cell proliferation and apoptosis", Cell Prolif, 45, pp.207~216 (2012)
- Chen Y, "The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer", J Biol Chem, 283, pp.17969~17978 (2008)
- Fang X, "Landscape of the SOX2 protein-protein interactome", Proteomics, 11, pp.921~934 (2011)
- Niu Y, "XRCC1 deficiency increased the DNA damage induced by gamma-ray in HepG2 cell : involvement of DSB repair and cell cycle arrest", Environ Toxicol Pharmacol, 36, pp.311~319 (2013)
- Chang HW, "Expression of Ku80 correlates with sensitivities to radiation in cancer cell lines of the head and neck", Oral Oncol, 42, pp.979~986 (2006)
- Ayene IS, "Ku protein targeting by Ku70small interfering RNA enhances human cancer cell response to topoisomerase II inhibitor and gamma radiation", Mol Cancer Ther, 4, pp.529~536 (2005)
- Bao S, "Glioma stem cells promote radioresistance by preferential activation of the DNA damage response", Nature, 444, pp.756~760 (2006)
- Diehn M, "Association of reactive oxygen species levels and radioresistance in cancer stem cells", Nature, 458, pp.780~783 (2009)
- Wang X, "SOX2enhances the migration and invasion of ovarian cancer cells via Src kinase", PLoS One, 9, pp.99594~ (2014)